(Total Views: 475)
Posted On: 06/10/2019 12:23:34 PM
Post# of 82688
Link for tomorrow's hearing Tuesday 2:30 pm est
https://www.judiciary.senate.gov/meetings/the...a-part-iii
This will be the third of three hearings held by the Senate IP Subcommittee to explore both current issues in U.S. patent eligibility as well as the proposed legislative fix to Section 101 of U.S. patent law meant to address those issues. There will be three witness panels to testify during this hearing. The first panel will include Manny Schecter, Chief Patent Counsel, IBM; Laurie Self, Senior Vice President and Counsel, Government Affairs, Qualcomm; Byron Holz, Senior Intellectual Property Rights Licensing Counsel, Nokia; Kim Chotkowski, Vice President, Head of Licensing Strategy and Operations, InterDigital; and Sean Reilly, Senior Vice President and Associate General Counsel, The Clearing House Payments Company. The second panel will include Laurie Hill, Vice President, Intellectual Property, Genentech; Sean George, CEO, Invitae; Gonzalo Merino, Vice President and Chief Intellectual Property Counsel, Regeneron Pharmaceuticals; Peter O’Neill, Executive Director, Cleveland Clinic Innovations; and Dr. David Spetzler, President and Chief Scientific Officer, Caris Life Sciences. The third panel will include Michael Blankstein, Senior Vice President and Deputy General Counsel, Patents and Licensing, Scientific Games; Corey Salsberg, Vice President, Global Head IP Affairs, Novartis; Nicolas Dupont, CEO and Executive Chairman, Cyborg Inc.; Robert DeBerardine, Chief Intellectual Property Counsel, Johnson & Johnson; and John Vandenberg, Partner, Klarquist Sparkman, LLP. More information on the panel roster for this hearing can be found here.
https://www.judiciary.senate.gov/meetings/the...a-part-iii
This will be the third of three hearings held by the Senate IP Subcommittee to explore both current issues in U.S. patent eligibility as well as the proposed legislative fix to Section 101 of U.S. patent law meant to address those issues. There will be three witness panels to testify during this hearing. The first panel will include Manny Schecter, Chief Patent Counsel, IBM; Laurie Self, Senior Vice President and Counsel, Government Affairs, Qualcomm; Byron Holz, Senior Intellectual Property Rights Licensing Counsel, Nokia; Kim Chotkowski, Vice President, Head of Licensing Strategy and Operations, InterDigital; and Sean Reilly, Senior Vice President and Associate General Counsel, The Clearing House Payments Company. The second panel will include Laurie Hill, Vice President, Intellectual Property, Genentech; Sean George, CEO, Invitae; Gonzalo Merino, Vice President and Chief Intellectual Property Counsel, Regeneron Pharmaceuticals; Peter O’Neill, Executive Director, Cleveland Clinic Innovations; and Dr. David Spetzler, President and Chief Scientific Officer, Caris Life Sciences. The third panel will include Michael Blankstein, Senior Vice President and Deputy General Counsel, Patents and Licensing, Scientific Games; Corey Salsberg, Vice President, Global Head IP Affairs, Novartis; Nicolas Dupont, CEO and Executive Chairman, Cyborg Inc.; Robert DeBerardine, Chief Intellectual Property Counsel, Johnson & Johnson; and John Vandenberg, Partner, Klarquist Sparkman, LLP. More information on the panel roster for this hearing can be found here.
(2)
(0)
